196 related articles for article (PubMed ID: 12196914)
1. Pharmacogenomic analysis: correlating molecular substructure classes with microarray gene expression data.
Blower PE; Yang C; Fligner MA; Verducci JS; Yu L; Richman S; Weinstein JN
Pharmacogenomics J; 2002; 2(4):259-71. PubMed ID: 12196914
[TBL] [Abstract][Full Text] [Related]
2. Data mining the NCI cancer cell line compound GI(50) values: identifying quinone subtypes effective against melanoma and leukemia cell classes.
Marx KA; O'Neil P; Hoffman P; Ujwal ML
J Chem Inf Comput Sci; 2003; 43(5):1652-67. PubMed ID: 14502500
[TBL] [Abstract][Full Text] [Related]
3. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.
Yamori T
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S74-9. PubMed ID: 12819939
[TBL] [Abstract][Full Text] [Related]
4. Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
Ganter B; Tugendreich S; Pearson CI; Ayanoglu E; Baumhueter S; Bostian KA; Brady L; Browne LJ; Calvin JT; Day GJ; Breckenridge N; Dunlea S; Eynon BP; Furness LM; Ferng J; Fielden MR; Fujimoto SY; Gong L; Hu C; Idury R; Judo MS; Kolaja KL; Lee MD; McSorley C; Minor JM; Nair RV; Natsoulis G; Nguyen P; Nicholson SM; Pham H; Roter AH; Sun D; Tan S; Thode S; Tolley AM; Vladimirova A; Yang J; Zhou Z; Jarnagin K
J Biotechnol; 2005 Sep; 119(3):219-44. PubMed ID: 16005536
[TBL] [Abstract][Full Text] [Related]
5. Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's Drug Discovery Program for Cancer and AIDS.
Weinstein JN; Myers T; Buolamwini J; Raghavan K; van Osdol W; Licht J; Viswanadhan VN; Kohn KW; Rubinstein LV; Koutsoukos AD
Stem Cells; 1994 Jan; 12(1):13-22. PubMed ID: 8142917
[TBL] [Abstract][Full Text] [Related]
6. Web-based tools for mining the NCI databases for anticancer drug discovery.
Fang X; Shao L; Zhang H; Wang S
J Chem Inf Comput Sci; 2004; 44(1):249-57. PubMed ID: 14741034
[TBL] [Abstract][Full Text] [Related]
7. A gene expression database for the molecular pharmacology of cancer.
Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
[TBL] [Abstract][Full Text] [Related]
8. Chemical data mining of the NCI human tumor cell line database.
Wang H; Klinginsmith J; Dong X; Lee AC; Guha R; Wu Y; Crippen GM; Wild DJ
J Chem Inf Model; 2007; 47(6):2063-76. PubMed ID: 17915856
[TBL] [Abstract][Full Text] [Related]
9. Large scale data mining approach for gene-specific standardization of microarray gene expression data.
Yoon S; Yang Y; Choi J; Seong J
Bioinformatics; 2006 Dec; 22(23):2898-904. PubMed ID: 17032674
[TBL] [Abstract][Full Text] [Related]
10. Comparison of seven methods for producing Affymetrix expression scores based on False Discovery Rates in disease profiling data.
Shedden K; Chen W; Kuick R; Ghosh D; Macdonald J; Cho KR; Giordano TJ; Gruber SB; Fearon ER; Taylor JM; Hanash S
BMC Bioinformatics; 2005 Feb; 6():26. PubMed ID: 15705192
[TBL] [Abstract][Full Text] [Related]
11. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
Huang R; Wallqvist A; Thanki N; Covell DG
Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895
[TBL] [Abstract][Full Text] [Related]
12. How to decide which are the most pertinent overly-represented features during gene set enrichment analysis.
Barriot R; Sherman DJ; Dutour I
BMC Bioinformatics; 2007 Sep; 8():332. PubMed ID: 17848190
[TBL] [Abstract][Full Text] [Related]
13. A protein expression database for the molecular pharmacology of cancer.
Myers TG; Anderson NL; Waltham M; Li G; Buolamwini JK; Scudiero DA; Paull KD; Sausville EA; Weinstein JN
Electrophoresis; 1997; 18(3-4):647-53. PubMed ID: 9150955
[TBL] [Abstract][Full Text] [Related]
14. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
Culhane AC; Perrière G; Higgins DG
BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Jung JJ; Jeung HC; Chung HC; Lee JO; Kim TS; Kim YT; Noh SH; Rha SY
Genomics; 2009 Jan; 93(1):52-61. PubMed ID: 18804159
[TBL] [Abstract][Full Text] [Related]
16. MILANO--custom annotation of microarray results using automatic literature searches.
Rubinstein R; Simon I
BMC Bioinformatics; 2005 Jan; 6():12. PubMed ID: 15661078
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of Actichip, a thematic microarray for the study of the actin cytoskeleton.
Muller J; Mehlen A; Vetter G; Yatskou M; Muller A; Chalmel F; Poch O; Friederich E; Vallar L
BMC Genomics; 2007 Aug; 8():294. PubMed ID: 17727702
[TBL] [Abstract][Full Text] [Related]
18. Impact of p53 knockout and topotecan treatment on gene expression profiles in human colon carcinoma cells: a pharmacogenomic study.
Daoud SS; Munson PJ; Reinhold W; Young L; Prabhu VV; Yu Q; LaRose J; Kohn KW; Weinstein JN; Pommier Y
Cancer Res; 2003 Jun; 63(11):2782-93. PubMed ID: 12782583
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Detecting and profiling tissue-selective genes.
Liang S; Li Y; Be X; Howes S; Liu W
Physiol Genomics; 2006 Jul; 26(2):158-62. PubMed ID: 16684803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]